Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03567213 · ClinicalTrials.gov registry record · NA

Investigation on the Cortical Communication (CortiCom) System

A NA study of Amyotrophic Lateral Sclerosis and Tetraplegia, sponsored by Johns Hopkins University.

Recruiting
Registry status
NA
Development phase
3
Enrollment target
1
Study location

NCT03567213 is a NA study of Amyotrophic Lateral Sclerosis and Tetraplegia that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 3 participants, below the 898-participant average among 102 other Amyotrophic Lateral Sclerosis trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03567213, a NA study of Amyotrophic Lateral Sclerosis and Tetraplegia, is actively recruiting participants, sponsored by Johns Hopkins University.

RECRUITING
Registry status
NA
Development phase
3 participants
Enrollment target
1
Study location

Study Summary

The CortiCom system consists of 510(k)-cleared components: platinum PMT subdural cortical electrode grids, a Blackrock Microsystems patient pedestal, and an external NeuroPort Neural Signal Processor. Up to two grids will be implanted in the brain, for a total channel count of up to 128 channels, for six months. In each participant, the grid(s) will be implanted over areas of cortex that encode speech and upper extremity movement.

Interventions

  • DEVICE Surgical implantation of CortiCom system

Study Locations (1)

Maryland

  • Johns Hopkins Medicine - Baltimore

Trial Details

FieldValue
Enrollment Target 3 participants
Start Date 2021-12-14
Est. Completion 2026-08-31
Phase NA

Sponsor

Johns Hopkins University

1,448 total trials

What the Registry Record Tells You About NCT03567213

The ClinicalTrials.gov registry entry for NCT03567213 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 898-participant average among 102 other Amyotrophic Lateral Sclerosis trials with a reported enrollment target (100% lower). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Amyotrophic Lateral Sclerosis appearing as the primary indexed condition, and to 1 intervention - of which Surgical implantation of CortiCom system is the first listed.

NCT03567213 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT03567213 about?

NCT03567213 is a clinical study titled "Investigation on the Cortical Communication (CortiCom) System". The CortiCom system consists of 510(k)-cleared components: platinum PMT subdural cortical electrode grids, a Blackrock Microsystems patient pedestal, and an external NeuroPort Neural Signal Processor. Up to two grids will be implanted in the brain, for a total channel count of up to 128 channels, fo...

What is the current status of trial NCT03567213?

This trial is currently recruiting. It is a NA study. The enrollment target is 3 participants. The study started on 2021-12-14. Estimated completion is 2026-08-31.

What conditions does trial NCT03567213 study?

This clinical trial studies the following conditions: Amyotrophic Lateral Sclerosis, Tetraplegia, Locked-in Syndrome, Brainstem Stroke.

What interventions are being tested in trial NCT03567213?

The interventions under investigation include: Surgical implantation of CortiCom system (DEVICE).

Who is sponsoring clinical trial NCT03567213?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03567213 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Amyotrophic Lateral Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.